These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 19364626)
1. High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide. Petronelli A; Saulle E; Pasquini L; Petrucci E; Mariani G; Biffoni M; Ferretti G; Scambia G; Benedetti-Panici P; Greggi S; Cognetti F; Russo MA; Sporn M; Testa U Cancer Lett; 2009 Sep; 282(2):214-28. PubMed ID: 19364626 [TBL] [Abstract][Full Text] [Related]
2. Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels. Riccioni R; Senese M; Diverio D; Riti V; Mariani G; Boe A; LoCoco F; FoĆ R; Peschle C; Sporn M; Testa U Leuk Res; 2008 Aug; 32(8):1244-58. PubMed ID: 18304628 [TBL] [Abstract][Full Text] [Related]
3. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300 [TBL] [Abstract][Full Text] [Related]
4. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells. Petrucci E; Pasquini L; Petronelli A; Saulle E; Mariani G; Riccioni R; Biffoni M; Ferretti G; Benedetti-Panici P; Cognetti F; Scambia G; Humphreys R; Peschle C; Testa U Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950 [TBL] [Abstract][Full Text] [Related]
5. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer. Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762 [TBL] [Abstract][Full Text] [Related]
6. The synthetic triterpenoid CDDO-Imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells. Liby K; Voong N; Williams CR; Risingsong R; Royce DB; Honda T; Gribble GW; Sporn MB; Letterio JJ Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4288-93. PubMed ID: 16857804 [TBL] [Abstract][Full Text] [Related]
7. The novel triterpenoid CDDO and its derivatives induce apoptosis by disruption of intracellular redox balance. Ikeda T; Sporn M; Honda T; Gribble GW; Kufe D Cancer Res; 2003 Sep; 63(17):5551-8. PubMed ID: 14500394 [TBL] [Abstract][Full Text] [Related]
8. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway. Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671 [TBL] [Abstract][Full Text] [Related]
9. Growth-inhibitory effect of a novel synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, on ovarian carcinoma cell lines not dependent on peroxisome proliferator-activated receptor-gamma expression. Melichar B; Konopleva M; Hu W; Melicharova K; Andreeff M; Freedman RS Gynecol Oncol; 2004 Apr; 93(1):149-54. PubMed ID: 15047229 [TBL] [Abstract][Full Text] [Related]
10. The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. Place AE; Suh N; Williams CR; Risingsong R; Honda T; Honda Y; Gribble GW; Leesnitzer LM; Stimmel JB; Willson TM; Rosen E; Sporn MB Clin Cancer Res; 2003 Jul; 9(7):2798-806. PubMed ID: 12855660 [TBL] [Abstract][Full Text] [Related]
11. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. Wahl H; Tan L; Griffith K; Choi M; Liu JR Gynecol Oncol; 2007 Apr; 105(1):104-12. PubMed ID: 17174384 [TBL] [Abstract][Full Text] [Related]
15. CDDO-Im is a stimulator of megakaryocytic differentiation. Petronelli A; Pelosi E; Santoro S; Saulle E; Cerio AM; Mariani G; Labbaye C; Testa U Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854 [TBL] [Abstract][Full Text] [Related]
16. Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid. Ikeda T; Nakata Y; Kimura F; Sato K; Anderson K; Motoyoshi K; Sporn M; Kufe D Mol Cancer Ther; 2004 Jan; 3(1):39-45. PubMed ID: 14749474 [TBL] [Abstract][Full Text] [Related]
17. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057 [TBL] [Abstract][Full Text] [Related]
18. 2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer. Samudio I; Konopleva M; Hail N; Shi YX; McQueen T; Hsu T; Evans R; Honda T; Gribble GW; Sporn M; Gilbert HF; Safe S; Andreeff M J Biol Chem; 2005 Oct; 280(43):36273-82. PubMed ID: 16118208 [TBL] [Abstract][Full Text] [Related]
19. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Duan Z; Ames RY; Ryan M; Hornicek FJ; Mankin H; Seiden MV Cancer Chemother Pharmacol; 2009 Mar; 63(4):681-9. PubMed ID: 18587580 [TBL] [Abstract][Full Text] [Related]
20. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways. Chintharlapalli S; Papineni S; Konopleva M; Andreef M; Samudio I; Safe S Mol Pharmacol; 2005 Jul; 68(1):119-28. PubMed ID: 15798084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]